CYTC - How High Can It Go! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : CYTC - How High Can It Go!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tony J Brice who wrote ()	3/17/1998 3:43:00 PM
From: MaximilianII	Read Replies (2) of 185

We are all aware that the Thin Prep process is reimbursed and that CYTYC exceeded the Street's profit expectation last quarter. IMO, the company is gaining momentum (despite the recent set-back). The pre-maturely released article from Blue Cross Blue Shield will draw attention to Cytyc's Thin Prep process and distinguish it from the competition. This will very likely generate more upward momentum for the company. I am aware of a sputum cytology company which uses the Thin Prep, and is highly pleased with it, confirming additional uses beside cervical cancer screening. We all know this is a long term winner. The stock carries one of the highest analyst ratings for timeliness, exceeded analysts earnings expectations last quarter (and will again this quarter IMO), the product will continue to be reimbursed. This is a unique oppotunity to increase your stake or get in for the first time. Don't hesitate.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next